Lv21
140 积分 2024-08-09 加入
Quality of Life Questionnaire-Bronchiectasis: final psychometric analyses and determination of minimal important difference scores
4小时前
待确认
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial
2个月前
已完结
VAV1 as a putative therapeutic target in autoimmune and chronic inflammatory diseases
2个月前
已完结
皖公网安备34019202002308
